6533b837fe1ef96bd12a1dee
RESEARCH PRODUCT
Granulocyte and natural killer activity in the elderly
Calogero CarusoFlorinda ListìAlfredo ColomboDiego CignaAntonio Tobia ColucciFrancesco GervasiGabriele Di LorenzoMarcella PotestioGiuseppina Colonna RomanoGiuseppina CandoreCarmela Rita Balistrerisubject
AdultMaleAgingmedicine.medical_specialtyNeutrophilschemical and pharmacologic phenomenaBiologyCD16Natural killer cellImmune systemInternal medicinemedicineHumansAgedAged 80 and overInnate immune systemEffectorChemotaxisImmunosenescenceMiddle AgedFas receptorKiller Cells Naturalmedicine.anatomical_structureEndocrinologyImmunologyFemaleDevelopmental Biologydescription
The deterioration of the immune system in ageing, 'immunosenescence', is thought to contribute to increased morbidity and mortality from infections and possibly autoimmune diseases and cancer. The most profound changes involve effector and immunoregulatory T-cell functions. Immunosenescence appears also to be related to changes in non specific immunity as well. In the present study we have assessed superoxide production, chemotaxis and the expression of the apoptosis-related molecule APO1/Fas (CD95) on neutrophils (PMN) from young and old subjects. Furthermore, we have measured the basal natural killer (NK) activity of young and elderly subjects and we have compared the number of CD16+ cells found in these two groups. We observed a significant decrease age-related both of formation of O2- and chemotaxis whereas no significant correlation between age and the expression of CD95 on granulocyte membrane was demonstrated, suggesting that an increase age-related of CD95-linked apoptosis of PMN should be not an important determinant in the decreased PMN function. We also observed a significant correlation between age and NK activity. The decreased NK cell function was not due to a decreased number of NK cells in effector cell preparations since the number of CD16+ cells was significantly increased in old subjects. In conclusion, our results show that in the elderly there is also a deficit of the aspecific immunity that might play a role in the pathogenic mechanisms of the immunosenescence.
year | journal | country | edition | language |
---|---|---|---|---|
1999-06-12 | Mechanisms of Ageing and Development |